Russell H - Search Results

1

Longitudinal Trends in Costs for Hospitalizations at Children's Hospitals.

Russell H, Hall M, Morse RB, Cutler GJ, Macy M, Bettenhausen JL, Lopez MA, Shah SS, Sills MR. Russell H, et al. Hosp Pediatr. 2020 Sep;10(9):797-801. doi: 10.1542/hpeds.2020-0009. Epub 2020 Aug 3. Hosp Pediatr. 2020. PMID: 32747333

2

Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations.

Whittle SB, Lopez MA, Russell HV. Whittle SB, et al. Pediatr Blood Cancer. 2019 Jul;66(7):e27739. doi: 10.1002/pbc.27739. Epub 2019 Apr 16. Pediatr Blood Cancer. 2019. PMID: 30989762 Free PMC article.

3

Care of Pediatric High-Cost Hospitalizations Across Hospital Types.

Lopez MA, Hall M, Auger KA, Bettenhausen JL, Colvin JD, Cutler GJ, Fieldston E, Macy ML, Morse R, Raphael JL, Russell H, Shah SS, Sills MR. Lopez MA, et al. Among authors: russell h. Hosp Pediatr. 2020 Mar;10(3):206-213. doi: 10.1542/hpeds.2019-0258. Epub 2020 Feb 5. Hosp Pediatr. 2020. PMID: 32024665

4

Financial Implications of Short Stay Pediatric Hospitalizations.

Synhorst DC, Hall M, Macy ML, Bettenhausen JL, Markham JL, Shah SS, Moretti A, Raval MV, Tian Y, Russell H, Hartley J, Morse R, Gay JC. Synhorst DC, et al. Among authors: russell h. Pediatrics. 2022 Apr 1;149(4):e2021052907. doi: 10.1542/peds.2021-052907. Pediatrics. 2022. PMID: 35355068

5

How Well Do All Patient Refined-Diagnosis-Related Groups Explain Costs of Pediatric Cancer Chemotherapy Admissions in the United States?

Russell H, Street A, Ho V. Russell H, et al. J Oncol Pract. 2016 May;12(5):e564-75. doi: 10.1200/JOP.2015.010330. Epub 2016 Apr 26. J Oncol Pract. 2016. PMID: 27118158 Free PMC article.

6

Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children.

Hassan SF, Mathur S, Magliaro TJ, Larimer EL, Ferrell LB, Vasudevan SA, Patterson DM, Louis CU, Russell HV, Nuchtern JG, Kim ES. Hassan SF, et al. J Pediatr Surg. 2012 Jun;47(6):1261-6. doi: 10.1016/j.jpedsurg.2012.03.040. J Pediatr Surg. 2012. PMID: 22703803 Review.

7

Bending the Cost Curve in Childhood Cancer.

Russell H, Bernhardt MB. Russell H, et al. Curr Hematol Malig Rep. 2016 Aug;11(4):295-302. doi: 10.1007/s11899-016-0332-3. Curr Hematol Malig Rep. 2016. PMID: 27193602 Review.

8

Inpatient versus outpatient vincristine, dactinomycin, and cyclophosphamide for pediatric cancers: Quality and cost implications.

Beaty RS, Bernhardt MB, Berger AH, Hesselgrave JE, Russell HV, Okcu MF. Beaty RS, et al. Among authors: russell hv. Pediatr Blood Cancer. 2015 Nov;62(11):1925-8. doi: 10.1002/pbc.25610. Epub 2015 Jul 7. Pediatr Blood Cancer. 2015. PMID: 26152314

9

Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.

Russell H, Swint JM, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu MF. Russell H, et al. Pediatr Blood Cancer. 2014 Jun;61(6):970-6. doi: 10.1002/pbc.24950. Epub 2014 Jan 22. Pediatr Blood Cancer. 2014. PMID: 24453105 Free PMC article.

10

Economic evaluation of pediatric cancer treatment: a systematic literature review.

Russell HV, Panchal J, Vonville H, Franzini L, Swint JM. Russell HV, et al. Pediatrics. 2013 Jan;131(1):e273-87. doi: 10.1542/peds.2012-0912. Epub 2012 Dec 24. Pediatrics. 2013. PMID: 23266919 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

761 results

Search Page